PBYI Annual D&A
$11.52 M
+$1.68 M+17.06%
31 December 2023
Summary:
As of January 23, 2025, PBYI annual depreciation & amortization is $11.52 million, with the most recent change of +$1.68 million (+17.06%) on December 31, 2023. During the last 3 years, it has risen by +$1.49 million (+14.81%). PBYI annual D&A is now at all-time high.PBYI Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PBYI Quarterly D&A
$2.88 M
-$30.00 K-1.03%
30 September 2024
Summary:
As of January 23, 2025, PBYI quarterly depreciation & amortization is $2.88 million, with the most recent change of -$30.00 thousand (-1.03%) on September 30, 2024. Over the past year, it has increased by +$2000.00 (+0.07%). PBYI quarterly D&A is now -3.36% below its all-time high of $2.98 million, reached on December 31, 2021.PBYI Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PBYI TTM D&A
$11.57 M
+$2000.00+0.02%
30 September 2024
Summary:
As of January 23, 2025, PBYI TTM depreciation & amortization is $11.57 million, with the most recent change of +$2000.00 (+0.02%) on September 30, 2024. Over the past year, it has increased by +$489.00 thousand (+4.41%). PBYI TTM D&A is now -1.65% below its all-time high of $11.77 million, reached on June 30, 2021.PBYI TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PBYI Depreciation And Amortization Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +17.1% | +0.1% | +4.4% |
| 3 y3 years | +14.8% | +16.9% | +11.9% |
| 5 y5 years | +56.0% | +16.9% | +11.9% |
PBYI Depreciation And Amortization High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +17.1% | -3.4% | +17.3% | at high | +17.6% |
| 5 y | 5-year | at high | +42.6% | -3.4% | +51.5% | -1.6% | +47.3% |
| alltime | all time | at high | -3.4% | >+9999.0% | -1.6% | >+9999.0% |
Puma Biotechnology Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $2.88 M(-1.0%) | $11.57 M(+0.0%) |
| June 2024 | - | $2.91 M(+0.4%) | $11.57 M(+0.3%) |
| Mar 2024 | - | $2.90 M(+0.3%) | $11.54 M(+0.2%) |
| Dec 2023 | $11.52 M(+17.1%) | $2.89 M(+0.5%) | $11.52 M(+3.9%) |
| Sept 2023 | - | $2.88 M(0.0%) | $11.08 M(+3.8%) |
| June 2023 | - | $2.88 M(-0.1%) | $10.68 M(+4.0%) |
| Mar 2023 | - | $2.88 M(+17.3%) | $10.26 M(+4.3%) |
| Dec 2022 | $9.84 M(-13.0%) | $2.45 M(-0.6%) | $9.84 M(-5.1%) |
| Sept 2022 | - | $2.47 M(+0.3%) | $10.37 M(+0.3%) |
| June 2022 | - | $2.46 M(+0.2%) | $10.34 M(-4.4%) |
| Mar 2022 | - | $2.46 M(-17.5%) | $10.81 M(-4.4%) |
| Dec 2021 | $11.30 M(+12.7%) | $2.98 M(+22.0%) | $11.30 M(+0.3%) |
| Sept 2021 | - | $2.44 M(-16.8%) | $11.28 M(-4.2%) |
| June 2021 | - | $2.94 M(-0.5%) | $11.77 M(+6.3%) |
| Mar 2021 | - | $2.95 M(+0.1%) | $11.07 M(+10.3%) |
| Dec 2020 | $10.03 M(+24.2%) | $2.95 M(+0.5%) | $10.03 M(+11.7%) |
| Sept 2020 | - | $2.93 M(+31.1%) | $8.98 M(+12.4%) |
| June 2020 | - | $2.24 M(+16.8%) | $8.00 M(+1.7%) |
| Mar 2020 | - | $1.92 M(+0.9%) | $7.86 M(-2.7%) |
| Dec 2019 | $8.08 M(+9.4%) | $1.90 M(-2.3%) | $8.08 M(-2.5%) |
| Sept 2019 | - | $1.94 M(-7.5%) | $8.28 M(-1.3%) |
| June 2019 | - | $2.10 M(-1.6%) | $8.39 M(+2.7%) |
| Mar 2019 | - | $2.13 M(+1.4%) | $8.18 M(+10.8%) |
| Dec 2018 | $7.38 M(+162.7%) | $2.10 M(+2.4%) | $7.38 M(+11.2%) |
| Sept 2018 | - | $2.06 M(+9.1%) | $6.64 M(+21.1%) |
| June 2018 | - | $1.88 M(+40.4%) | $5.48 M(+41.5%) |
| Mar 2018 | - | $1.34 M(-1.4%) | $3.88 M(+37.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2017 | $2.81 M(+144.6%) | $1.36 M(+51.1%) | $2.81 M(+38.1%) |
| Sept 2017 | - | $900.00 K(+228.5%) | $2.04 M(+63.5%) |
| June 2017 | - | $274.00 K(-1.1%) | $1.25 M(+2.2%) |
| Mar 2017 | - | $277.00 K(-52.6%) | $1.22 M(+6.0%) |
| Dec 2016 | $1.15 M(+48.1%) | $584.00 K(+430.9%) | $1.15 M(+48.6%) |
| Sept 2016 | - | $110.00 K(-55.5%) | $773.00 K(-10.3%) |
| June 2016 | - | $247.00 K(+18.8%) | $862.00 K(+7.2%) |
| Mar 2016 | - | $208.00 K(0.0%) | $804.00 K(+3.6%) |
| Dec 2015 | $776.00 K(+23.8%) | $208.00 K(+4.5%) | $776.00 K(+2.5%) |
| Sept 2015 | - | $199.00 K(+5.3%) | $757.00 K(+5.6%) |
| June 2015 | - | $189.00 K(+5.0%) | $717.00 K(+6.4%) |
| Mar 2015 | - | $180.00 K(-4.8%) | $674.00 K(+7.5%) |
| Dec 2014 | $627.00 K(+48.2%) | $189.00 K(+18.9%) | $627.00 K(+11.4%) |
| Sept 2014 | - | $159.00 K(+8.9%) | $563.00 K(+9.7%) |
| June 2014 | - | $146.00 K(+9.8%) | $513.00 K(+10.1%) |
| Mar 2014 | - | $133.00 K(+6.4%) | $466.00 K(+10.2%) |
| Dec 2013 | $423.00 K(+59.6%) | $125.00 K(+14.7%) | $423.00 K(+12.5%) |
| Sept 2013 | - | $109.00 K(+10.1%) | $376.00 K(+11.9%) |
| June 2013 | - | $99.00 K(+10.0%) | $336.00 K(+9.8%) |
| Mar 2013 | - | $90.00 K(+15.4%) | $306.00 K(+15.5%) |
| Dec 2012 | $265.00 K(+2309.1%) | $78.00 K(+13.0%) | $265.00 K(+34.0%) |
| Sept 2012 | - | $69.00 K(0.0%) | $197.70 K(+53.4%) |
| June 2012 | - | $69.00 K(+40.8%) | $128.90 K(+114.5%) |
| Mar 2012 | - | $49.00 K(+357.9%) | $60.10 K(+441.4%) |
| Dec 2011 | $11.00 K(>+9900.0%) | $10.70 K(+5250.0%) | $11.10 K(+2675.0%) |
| Sept 2011 | - | $200.00(0.0%) | $400.00(+100.0%) |
| June 2011 | - | $200.00 | $200.00 |
| Dec 2010 | $0.00 | - | - |
FAQ
- What is Puma Biotechnology annual depreciation & amortization?
- What is the all time high annual D&A for Puma Biotechnology?
- What is Puma Biotechnology annual D&A year-on-year change?
- What is Puma Biotechnology quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Puma Biotechnology?
- What is Puma Biotechnology quarterly D&A year-on-year change?
- What is Puma Biotechnology TTM depreciation & amortization?
- What is the all time high TTM D&A for Puma Biotechnology?
- What is Puma Biotechnology TTM D&A year-on-year change?
What is Puma Biotechnology annual depreciation & amortization?
The current annual D&A of PBYI is $11.52 M
What is the all time high annual D&A for Puma Biotechnology?
Puma Biotechnology all-time high annual depreciation & amortization is $11.52 M
What is Puma Biotechnology annual D&A year-on-year change?
Over the past year, PBYI annual depreciation & amortization has changed by +$1.68 M (+17.06%)
What is Puma Biotechnology quarterly depreciation & amortization?
The current quarterly D&A of PBYI is $2.88 M
What is the all time high quarterly D&A for Puma Biotechnology?
Puma Biotechnology all-time high quarterly depreciation & amortization is $2.98 M
What is Puma Biotechnology quarterly D&A year-on-year change?
Over the past year, PBYI quarterly depreciation & amortization has changed by +$2000.00 (+0.07%)
What is Puma Biotechnology TTM depreciation & amortization?
The current TTM D&A of PBYI is $11.57 M
What is the all time high TTM D&A for Puma Biotechnology?
Puma Biotechnology all-time high TTM depreciation & amortization is $11.77 M
What is Puma Biotechnology TTM D&A year-on-year change?
Over the past year, PBYI TTM depreciation & amortization has changed by +$489.00 K (+4.41%)